1-anilino-8-naphthalenesulfonate has been researched along with Chronic Hepatitis C in 70 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Excerpt | Relevance | Reference |
---|---|---|
" Single nucleotide polymorphisms (SNPs) near the epidermal growth factor (EGF) (rs4444903), IL28B (rs12979860), and PNPLA3 (rs738409) loci are associated with treatment response, fibrosis, and hepatocellular carcinoma in non-transplant hepatitis C, but allograft population data are limited." | 3.83 | Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. ( Chung, RT; Corey, KE; Curry, MP; Fuchs, BC; Gao, T; Gogela, NA; Gordon, FD; Johnson, KB; King, LY; Kothari, D; Lee, JH; Lin, MV; Misdraji, J; Mueller, JL; Nephew, LD; Simpson, MA; Tanabe, KK; Wei, L; Zheng, H, 2016) |
"The incidence of hepatocellular carcinoma (HCC) is increasing in Western countries." | 2.50 | Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. ( Bontempi, G; Burza, MA; Corradini, SG; Deltenre, P; Devière, J; Donati, B; Falleti, E; Franchimont, D; Guyot, E; Hamza, S; Henrion, J; Hillon, P; Mathurin, P; Moreno, C; Nahon, P; Nischalke, HD; Romeo, S; Spengler, U; Toniutto, P; Trépo, E; Valenti, L, 2014) |
"However, the development of hepatocellular carcinoma (HCC), even after the achievement of SVR, continues to be a serious problem." | 1.72 | Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication. ( Furusyo, N; Ikezaki, H; Matsumoto, Y; Murata, M; Ogawa, E; Ohta, A; Yamasaki, S, 2022) |
"Significant liver fibrosis regression occurs after hepatitis C virus (HCV) therapy." | 1.72 | Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. ( Avihingsanon, A; Chuaypen, N; Hiranrat, P; Siripongsakun, S; Tangkijvanich, P; Tanpowpong, N, 2022) |
"Nonalcoholic fatty liver disease (NAFLD), insulin resistance and liver fibrosis are prevalent in individuals co-infected with HIV type 1 (HIV-1)/hepatitis C virus (HCV), even after HCV eradication." | 1.62 | Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus. ( Bechini, J; Clotet, B; de Cid, R; Franco, S; Galván-Femenía, I; Horneros, J; Llibre, JM; Martínez, MA; Ouchi, D; Perez, R; Soldevila, L; Tenesa, M; Tural, C, 2021) |
"Among 261 patients with liver cirrhosis, rs738409 (GG) genotype was not associated with time-to-HCC development on multivariate Cox regression (P = 0." | 1.48 | Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study. ( Chang, KC; Chen, CH; Chiu, KW; Hu, TH; Huang, CM; Hung, CH; Kee, KM; Kuo, YH; Lin, JT; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Yen, YH, 2018) |
"The study included 317 individuals with liver cirrhosis, 154 individuals with liver fibrosis, and 498 controls." | 1.46 | PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population. ( Kiudelis, G; Kondrackiene, J; Kupcinskas, J; Kupcinskas, L; Lammert, F; Petrenkiene, V; Skieceviciene, J; Steponaitiene, R; Sumskiene, J; Valantiene, I; Varkalaitė, G, 2017) |
"Acute pancreatitis is a rare complication of PEG-IFN-α administration." | 1.43 | Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C. ( Bae, WK; Choi, JW; Kim, JG; Kim, JW; Kim, KA; Lee, JS; Paik, WH; Song, TJ, 2016) |
"Patients with advanced liver fibrosis had higher proportions of the GG genotype (14." | 1.42 | Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. ( Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Liang, PC; Lin, YH; Lin, ZY; Tai, CM; Yang, HL; Yeh, ML; Yu, ML, 2015) |
"Histological features of steatohepatitis in CHC were assessed using the Bedossa classification." | 1.42 | PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C. ( Abate, ML; Bugianesi, E; Cabibi, D; Cammà, C; Craxì, A; Di Marco, V; Eslam, M; George, J; Grimaudo, S; Macaluso, FS; McLeod, D; Petta, S; Pipitone, RM; Rosso, C; Smedile, A; Vanni, E, 2015) |
"Advanced liver fibrosis was neither associated with PNPLA3 (p = 0." | 1.42 | The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. ( Aichelburg, MC; Bota, S; Bucsics, T; Ferenci, P; Grabmeier-Pfistershammer, K; Mandorfer, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Scheiner, B; Schwabl, P; Stättermayer, A; Trauner, M, 2015) |
"Hepatic cirrhosis was associated with a higher aspartate aminotransferase/platelet ratio index (APRI), no fatty change of the liver, higher BMI and higher AFP levels." | 1.39 | No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. ( Jiang, X; Kanda, T; Miyamura, T; Nakamoto, S; Nakamura, M; Wu, S; Yokosuka, O, 2013) |
"Insulin resistance is more common in carriers of the T allele of SNP rs12979860 than in CC homozygotes and may partly explain the poor outcome of peginterferon/ribavirin therapy in these patients." | 1.38 | Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. ( Beinhardt, S; Datz, C; Ferenci, P; Hofer, H; Krebs, M; Rutter, K; Scherzer, TM; Stadlmayr, A; Stättermayer, AF; Steindl-Munda, P; Trauner, M; Wrba, F, 2012) |
"We performed a 2-stage GWA study of liver fibrosis progression related to HCV infection." | 1.38 | Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. ( Abel, L; Argiro, L; Bibert, S; Bochud, PY; Boland, A; Booth, DR; Bourlière, M; Bousquet, L; Bréchot, C; Casanova, JL; Cerny, A; Dufour, JF; George, J; Guergnon, J; Halfon, P; Heim, MH; Hirsch, H; Jacobson, IM; Jouanguy, E; Kutalik, Z; Malinverni, R; Martinetti, G; Moradpour, D; Müllhaupt, B; Munteanu, M; Nalpas, B; Negro, F; Patin, E; Pol, S; Poynard, T; Rice, CM; Semela, D; Stewart, G; Suppiah, V; Talal, AH; Theodorou, I, 2012) |
"Two patients experienced episodes of acute pancreatitis shortly after starting treatment with interferon alfa-2b (IFN-alpha) for a chronic hepatitis C infection." | 1.31 | Acute pancreatitis attributed to the use of interferon alfa-2b. ( Bekkering, FC; Belaiche, J; Brouwer, JT; Delwaide, J; Eland, IA; Houbiers, G; Rasch, MC; Stricker, BH; Sturkenboom, MJ, 2000) |
"Patients with liver cirrhosis had serum levels of amylase and lipase significantly higher than both the healthy subjects and the patients with CAH, while no significant differences were found in serum levels of these enzymes in patients with CAH as compared to the healthy subjects." | 1.30 | Serum pancreatic enzyme concentrations in chronic viral liver diseases. ( Andreone, P; Barakat, B; Bernardi, M; Billi, P; Cursaro, C; Fiocchi, M; Gramenzi, A; Miglio, F; Morselli-Labate, AM; Pezzilli, R; Sama, C, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.43) | 18.2507 |
2000's | 4 (5.71) | 29.6817 |
2010's | 55 (78.57) | 24.3611 |
2020's | 10 (14.29) | 2.80 |
Authors | Studies |
---|---|
Franco, S | 1 |
Horneros, J | 1 |
Soldevila, L | 1 |
Ouchi, D | 1 |
Galván-Femenía, I | 1 |
de Cid, R | 1 |
Tenesa, M | 1 |
Bechini, J | 1 |
Perez, R | 1 |
Llibre, JM | 1 |
Clotet, B | 1 |
Tural, C | 1 |
Martínez, MA | 1 |
Gavril, OI | 1 |
Arhire, LI | 1 |
Gavrilescu, O | 1 |
Dranga, M | 1 |
Barboi, O | 1 |
Gavril, RS | 1 |
Popescu, R | 1 |
Cijevschi Prelipcean, C | 1 |
Trifan, AV | 1 |
Mihai, C | 1 |
Ohta, A | 1 |
Ogawa, E | 1 |
Murata, M | 1 |
Matsumoto, Y | 1 |
Yamasaki, S | 1 |
Ikezaki, H | 1 |
Furusyo, N | 1 |
Chuaypen, N | 2 |
Siripongsakun, S | 1 |
Hiranrat, P | 1 |
Tanpowpong, N | 1 |
Avihingsanon, A | 1 |
Tangkijvanich, P | 2 |
Senkerikova, R | 1 |
Frankova, S | 1 |
Jirsa, M | 1 |
Kreidlova, M | 1 |
Merta, D | 1 |
Neroldova, M | 1 |
Chmelova, K | 1 |
Spicak, J | 1 |
Sperl, J | 1 |
Crisan, D | 1 |
Grigorescu, M | 1 |
Crisan, N | 1 |
Craciun, R | 1 |
Lupsor, M | 1 |
Radu, C | 1 |
Grigorescu, MD | 1 |
Suciu, A | 1 |
Epure, F | 1 |
Avram, L | 1 |
Leach, N | 1 |
Youssef, SS | 1 |
Abbas, EAER | 1 |
Youness, RA | 1 |
Elemeery, MN | 1 |
Nasr, AS | 1 |
Seif, S | 1 |
Magri, MC | 3 |
Manchiero, C | 3 |
Prata, TVG | 2 |
Nunes, AKDS | 3 |
Oliveira Junior, JS | 1 |
Dantas, BP | 3 |
Tengan, FM | 3 |
Miki, D | 1 |
Akita, T | 1 |
Kurisu, A | 1 |
Kawaoka, T | 1 |
Nakajima, T | 1 |
Hige, S | 1 |
Karino, Y | 1 |
Toyoda, H | 1 |
Kumada, T | 1 |
Tsuge, M | 1 |
Hiramatsu, A | 1 |
Imamura, M | 1 |
Aikata, H | 1 |
Hayes, CN | 1 |
Honda, K | 1 |
Seike, M | 1 |
Akuta, N | 1 |
Kobayashi, M | 2 |
Kumada, H | 2 |
Tanaka, J | 1 |
Chayama, K | 1 |
Agrawal, T | 1 |
Gaggar, A | 1 |
Subramanian, M | 1 |
Kottilil, S | 1 |
Choudhary, A | 1 |
Rao, PN | 1 |
Shah, S | 1 |
Trehanpati, N | 1 |
Alvarez, MSM | 1 |
Iogi, AA | 1 |
Alves, GM | 1 |
Oliveira, AIN | 1 |
Malta, FM | 1 |
Zitelli, PMY | 1 |
Salles, APM | 1 |
Gomes-Gouvea, MS | 1 |
Nastri, ACS | 1 |
Pinho, JRR | 1 |
Carrilho, FJ | 1 |
Oliveira, CP | 1 |
Mendes-Corrêa, MC | 1 |
Pessoa, MG | 1 |
Mazo, DF | 1 |
Kupcinskas, J | 1 |
Valantiene, I | 1 |
Varkalaitė, G | 1 |
Steponaitiene, R | 1 |
Skieceviciene, J | 1 |
Sumskiene, J | 1 |
Petrenkiene, V | 1 |
Kondrackiene, J | 1 |
Kiudelis, G | 1 |
Lammert, F | 1 |
Kupcinskas, L | 1 |
Huang, CM | 2 |
Chang, KC | 2 |
Hung, CH | 2 |
Chiu, KW | 2 |
Lu, SN | 3 |
Wang, JH | 2 |
Chen, CH | 2 |
Kee, KM | 2 |
Kuo, YH | 2 |
Tsai, MC | 2 |
Tseng, PL | 2 |
Lin, MT | 2 |
Wu, CK | 2 |
Hu, TH | 2 |
Cho, CL | 1 |
Yen, YH | 2 |
Lin, JT | 1 |
Mazza, CC | 1 |
Barone, AA | 1 |
Jiménez-Sousa, MÁ | 2 |
Gómez-Moreno, AZ | 1 |
Pineda-Tenor, D | 1 |
Sánchez-Ruano, JJ | 1 |
Fernández-Rodríguez, A | 1 |
Artaza-Varasa, T | 1 |
Gómez-Sanz, A | 1 |
Martín-Vicente, M | 1 |
Vázquez-Morón, S | 2 |
Resino, S | 2 |
Mandorfer, M | 3 |
Scheiner, B | 2 |
Stättermayer, AF | 4 |
Schwabl, P | 3 |
Paternostro, R | 1 |
Bauer, D | 1 |
Schaefer, B | 1 |
Zoller, H | 1 |
Peck-Radosavljevic, M | 3 |
Trauner, M | 4 |
Reiberger, T | 3 |
Ferenci, P | 5 |
Ferlitsch, A | 2 |
Sherman, KE | 1 |
Rouster, SD | 1 |
Kang, M | 1 |
Umbleja, T | 1 |
Sterling, R | 1 |
Butt, AA | 1 |
Zampino, R | 3 |
Macera, M | 4 |
Cirillo, G | 5 |
Pafundi, PC | 1 |
Rinaldi, L | 1 |
Coppola, N | 5 |
Pisaturo, M | 3 |
Adinolfi, LE | 4 |
Miraglia Del Giudice, E | 3 |
Ingrosso, D | 1 |
Capasso, R | 1 |
Raksayot, M | 1 |
Khlaiphuengsin, A | 1 |
Pinjaroen, N | 1 |
Treeprasertsuk, S | 1 |
Poovorawan, Y | 1 |
Tanaka, Y | 2 |
Boemio, A | 2 |
Marrone, A | 3 |
Sagnelli, E | 3 |
Perrone, L | 1 |
Trépo, E | 2 |
Nahon, P | 2 |
Bontempi, G | 1 |
Valenti, L | 8 |
Falleti, E | 1 |
Nischalke, HD | 1 |
Hamza, S | 1 |
Corradini, SG | 1 |
Burza, MA | 2 |
Guyot, E | 2 |
Donati, B | 2 |
Spengler, U | 1 |
Hillon, P | 1 |
Toniutto, P | 1 |
Henrion, J | 1 |
Franchimont, D | 2 |
Devière, J | 2 |
Mathurin, P | 1 |
Moreno, C | 2 |
Romeo, S | 3 |
Deltenre, P | 1 |
Dongiovanni, P | 5 |
Fares, R | 1 |
Lombardi, R | 1 |
Mancina, RM | 1 |
Nakamura, M | 1 |
Kanda, T | 1 |
Nakamoto, S | 1 |
Miyamura, T | 1 |
Jiang, X | 1 |
Wu, S | 1 |
Yokosuka, O | 1 |
Florio, A | 1 |
Del Giudice, EM | 2 |
Moritou, Y | 2 |
Ikeda, F | 2 |
Iwasaki, Y | 2 |
Baba, N | 1 |
Takaguchi, K | 1 |
Senoh, T | 1 |
Nagano, T | 1 |
Takeuchi, Y | 2 |
Yasunaka, T | 2 |
Ohnishi, H | 2 |
Miyake, Y | 2 |
Takaki, A | 2 |
Nouso, K | 2 |
Yamamoto, K | 2 |
Payer, BA | 2 |
Steiner, S | 1 |
Aichelburg, MC | 2 |
Obermayer-Pietsch, B | 1 |
Grabmeier-Pfistershammer, K | 2 |
De Nicola, S | 3 |
Aghemo, A | 4 |
Cheroni, C | 1 |
D'Ambrosio, R | 1 |
Pedrazzini, M | 1 |
Marabita, F | 1 |
Donnici, L | 1 |
Maggioni, M | 2 |
Fargion, S | 6 |
Colombo, M | 4 |
De Francesco, R | 1 |
Huang, CF | 2 |
Dai, CY | 2 |
Yeh, ML | 2 |
Huang, CI | 2 |
Tai, CM | 1 |
Hsieh, MH | 1 |
Liang, PC | 1 |
Lin, YH | 1 |
Hsieh, MY | 2 |
Yang, HL | 2 |
Huang, JF | 2 |
Lin, ZY | 2 |
Chen, SC | 2 |
Yu, ML | 2 |
Chuang, WL | 2 |
Yasui, K | 1 |
Kawaguchi, T | 1 |
Shima, T | 1 |
Mitsuyoshi, H | 1 |
Seki, K | 1 |
Sendo, R | 1 |
Mizuno, M | 1 |
Itoh, Y | 1 |
Matsuda, F | 1 |
Okanoue, T | 1 |
Rosa, Z | 1 |
Stanzione, M | 1 |
Grandone, A | 2 |
Petta, S | 2 |
Vanni, E | 1 |
Bugianesi, E | 1 |
Rosso, C | 1 |
Cabibi, D | 2 |
Cammà, C | 2 |
Di Marco, V | 2 |
Eslam, M | 1 |
Grimaudo, S | 2 |
Macaluso, FS | 2 |
McLeod, D | 1 |
Pipitone, RM | 2 |
Abate, ML | 1 |
Smedile, A | 1 |
George, J | 2 |
Craxì, A | 2 |
Chen, JJ | 1 |
Chen, YL | 1 |
Maida, M | 1 |
Sferrazza, S | 1 |
Ali, M | 1 |
Yopp, A | 1 |
Gopal, P | 1 |
Beg, MS | 1 |
Zhu, H | 1 |
Lee, W | 1 |
Singal, AG | 1 |
Tamaki, N | 1 |
Kurosaki, M | 1 |
Higuchi, M | 1 |
Takada, H | 1 |
Nakakuki, N | 1 |
Yasui, Y | 1 |
Suzuki, S | 1 |
Tsuchiya, K | 1 |
Nakanishi, H | 1 |
Itakura, J | 1 |
Takahashi, Y | 1 |
Ogawa, S | 1 |
Asahina, Y | 1 |
Izumi, N | 1 |
Enache, EL | 1 |
Sin, A | 1 |
Bancu, L | 1 |
Ramière, C | 1 |
Diaz, O | 1 |
André, P | 1 |
Enache, LS | 1 |
Fan, JH | 1 |
Xiang, MQ | 1 |
Li, QL | 1 |
Shi, HT | 1 |
Guo, JJ | 1 |
Bucsics, T | 1 |
Bota, S | 1 |
Stättermayer, A | 1 |
Berenguer, J | 1 |
García-Álvarez, M | 1 |
Gutierrez-Rivas, M | 1 |
Aldámiz-Echevarria, T | 1 |
Tejerina, F | 1 |
Diez, C | 1 |
Sagnelli, C | 1 |
Merli, M | 1 |
Uberti-Foppa, C | 1 |
Hasson, H | 1 |
Salpietro, S | 1 |
Minichini, C | 1 |
Lazzarin, A | 1 |
Mueller, JL | 1 |
King, LY | 1 |
Johnson, KB | 1 |
Gao, T | 1 |
Nephew, LD | 1 |
Kothari, D | 1 |
Simpson, MA | 1 |
Zheng, H | 1 |
Wei, L | 1 |
Corey, KE | 1 |
Misdraji, J | 1 |
Lee, JH | 1 |
Lin, MV | 1 |
Gogela, NA | 1 |
Fuchs, BC | 1 |
Tanabe, KK | 1 |
Gordon, FD | 1 |
Curry, MP | 1 |
Chung, RT | 2 |
Choi, JW | 1 |
Lee, JS | 1 |
Paik, WH | 1 |
Song, TJ | 1 |
Kim, JW | 1 |
Bae, WK | 1 |
Kim, KA | 1 |
Kim, JG | 1 |
Núñez-Torres, R | 1 |
Macías, J | 1 |
Mancebo, M | 1 |
Frías, M | 1 |
Dolci, G | 1 |
Téllez, F | 1 |
Merino, D | 1 |
Merchante, N | 1 |
Gómez-Mateos, J | 1 |
Guaraldi, G | 1 |
Rivero-Juárez, A | 1 |
Pineda, JA | 1 |
Real, LM | 1 |
Cai, T | 1 |
Dufour, JF | 2 |
Muellhaupt, B | 1 |
Gerlach, T | 1 |
Heim, M | 1 |
Moradpour, D | 2 |
Cerny, A | 2 |
Malinverni, R | 2 |
Kaddai, V | 1 |
Bochud, M | 1 |
Negro, F | 2 |
Bochud, PY | 2 |
Müller, T | 1 |
Buch, S | 1 |
Berg, T | 1 |
Hampe, J | 1 |
Stickel, F | 1 |
Rumi, M | 1 |
Galmozzi, E | 1 |
Del Menico, B | 1 |
Fracanzani, AL | 2 |
Rametta, R | 2 |
Friedman, SL | 1 |
Pradat, P | 1 |
Potthoff, A | 1 |
Momozawa, Y | 1 |
Quertinmont, E | 1 |
Gustot, T | 1 |
Lemmers, A | 1 |
Berthillon, P | 1 |
Amininejad, L | 1 |
Chevallier, M | 1 |
Schlué, J | 1 |
Kreipe, H | 1 |
Manns, M | 1 |
Trépo, C | 1 |
Sninsky, J | 1 |
Wedemeyer, H | 1 |
Kalambokis, GN | 1 |
Tsianos, EV | 1 |
do O, NT | 1 |
Eurich, D | 1 |
Trautwein, C | 1 |
Neuhaus, P | 1 |
Neumann, UP | 1 |
Wasmuth, HE | 1 |
Schaefer, EA | 1 |
Maggioni, P | 1 |
Motta, BM | 2 |
Rumi, MG | 1 |
Clark, PJ | 1 |
Thompson, AJ | 1 |
Zhu, Q | 1 |
Vock, DM | 1 |
Zhu, M | 1 |
Patel, K | 1 |
Harrison, SA | 1 |
Naggie, S | 1 |
Ge, D | 1 |
Tillmann, HL | 1 |
Urban, TJ | 1 |
Shianna, K | 1 |
Fellay, J | 1 |
Goodman, Z | 1 |
Noviello, S | 1 |
Pedicone, LD | 1 |
Afdhal, N | 1 |
Sulkowski, M | 1 |
Albrecht, JK | 1 |
Goldstein, DB | 1 |
McHutchison, JG | 1 |
Muir, AJ | 1 |
Rutter, K | 1 |
Beinhardt, S | 1 |
Scherzer, TM | 1 |
Stadlmayr, A | 1 |
Hofer, H | 1 |
Wrba, F | 1 |
Steindl-Munda, P | 1 |
Krebs, M | 1 |
Datz, C | 1 |
Patin, E | 1 |
Kutalik, Z | 1 |
Guergnon, J | 1 |
Bibert, S | 1 |
Nalpas, B | 1 |
Jouanguy, E | 1 |
Munteanu, M | 1 |
Bousquet, L | 1 |
Argiro, L | 1 |
Halfon, P | 1 |
Boland, A | 1 |
Müllhaupt, B | 1 |
Semela, D | 1 |
Heim, MH | 1 |
Hirsch, H | 1 |
Martinetti, G | 1 |
Suppiah, V | 1 |
Stewart, G | 1 |
Booth, DR | 1 |
Casanova, JL | 1 |
Bréchot, C | 1 |
Rice, CM | 1 |
Talal, AH | 1 |
Jacobson, IM | 1 |
Bourlière, M | 1 |
Theodorou, I | 1 |
Poynard, T | 1 |
Pol, S | 1 |
Abel, L | 1 |
Miyashita, M | 1 |
Ito, T | 1 |
Sakaki, M | 1 |
Kajiwara, A | 1 |
Nozawa, H | 1 |
Hiroishi, K | 1 |
Imawari, M | 1 |
Hagihara, H | 1 |
Kuwaki, K | 1 |
Nakamura, S | 1 |
Shiraha, H | 1 |
Ruscica, M | 1 |
Steffani, L | 1 |
Canavesi, E | 1 |
Mozzi, E | 1 |
Roviaro, G | 1 |
Magni, P | 1 |
Rembeck, K | 1 |
Maglio, C | 1 |
Lagging, M | 1 |
Christensen, PB | 1 |
Färkkilä, M | 1 |
Langeland, N | 1 |
Buhl, MR | 1 |
Pedersen, C | 1 |
Mørch, K | 1 |
Norkrans, G | 1 |
Hellstrand, K | 1 |
Lindh, M | 1 |
Pirazzi, C | 1 |
Westin, J | 1 |
Sutton, A | 1 |
Rufat, P | 1 |
Laguillier, C | 1 |
Mansouri, A | 1 |
Moreau, R | 1 |
Ganne-Carrié, N | 1 |
Beaugrand, M | 1 |
Charnaux, N | 1 |
Trinchet, JC | 1 |
Yoffe, B | 1 |
Bagri, AS | 1 |
Tran, T | 1 |
Dural, AT | 1 |
Shtenberg, KM | 1 |
Khaoustov, VI | 1 |
Katakura, Y | 1 |
Yotsuyanagi, H | 1 |
Hashizume, K | 1 |
Okuse, C | 1 |
Okuse, N | 1 |
Nishikawa, K | 1 |
Suzuki, M | 1 |
Iino, S | 1 |
Itoh, F | 1 |
Chen, CL | 1 |
Yang, HI | 1 |
Yang, WS | 1 |
Liu, CJ | 1 |
Chen, PJ | 1 |
You, SL | 1 |
Wang, LY | 1 |
Sun, CA | 1 |
Chen, DS | 1 |
Chen, CJ | 1 |
Pezzilli, R | 1 |
Andreone, P | 1 |
Morselli-Labate, AM | 1 |
Sama, C | 1 |
Billi, P | 1 |
Cursaro, C | 1 |
Barakat, B | 1 |
Gramenzi, A | 1 |
Fiocchi, M | 1 |
Miglio, F | 1 |
Bernardi, M | 1 |
Eland, IA | 1 |
Rasch, MC | 1 |
Sturkenboom, MJ | 1 |
Bekkering, FC | 1 |
Brouwer, JT | 1 |
Delwaide, J | 1 |
Belaiche, J | 1 |
Houbiers, G | 1 |
Stricker, BH | 1 |
4 reviews available for 1-anilino-8-naphthalenesulfonate and Chronic Hepatitis C
Article | Year |
---|---|
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.
Topics: Carcinoma, Hepatocellular; Hepatitis C, Chronic; Humans; Lipase; Liver Cirrhosis, Alcoholic; Liver N | 2014 |
PNPLA3 I148M polymorphism and progressive liver disease.
Topics: Carcinoma, Hepatocellular; Cholangitis, Sclerosing; Disease Progression; Fatty Liver; Fatty Liver, A | 2013 |
PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis.
Topics: Asian People; Fatty Liver; Hepatitis C, Chronic; Humans; Lipase; Liver Cirrhosis; Membrane Proteins; | 2016 |
The impact of human gene polymorphisms on HCV infection and disease outcome.
Topics: Antiviral Agents; Disease Progression; Genetic Predisposition to Disease; Genotype; Hepacivirus; Hep | 2011 |
2 trials available for 1-anilino-8-naphthalenesulfonate and Chronic Hepatitis C
Article | Year |
---|---|
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
Topics: Adult; Cohort Studies; Female; Hepatitis C, Chronic; HIV Infections; Humans; Lipase; Male; Membrane | 2018 |
PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.
Topics: Adult; Alleles; Antiviral Agents; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; | 2012 |
64 other studies available for 1-anilino-8-naphthalenesulfonate and Chronic Hepatitis C
Article | Year |
---|---|
Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus.
Topics: Acyltransferases; Adenosine Deaminase; Coinfection; Hepacivirus; Hepatitis C, Chronic; HIV Infection | 2021 |
Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
Topics: Antiviral Agents; Fatty Liver; Genotype; Hepatitis C, Chronic; Humans; Lipase; Liver Cirrhosis; Memb | 2021 |
Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Topics: Acyltransferases; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Genotype; Hepacivirus; Hepa | 2022 |
Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants.
Topics: Antiviral Agents; Fatty Liver; Fibrosis; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; H | 2022 |
PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
Topics: Alleles; Carcinoma, Hepatocellular; Case-Control Studies; Cross-Sectional Studies; Female; Genetic P | 2019 |
Association between PNPLA3[G]/I148M variant, steatosis and fibrosis stage in hepatitis C virus - genetic matters.
Topics: Antiviral Agents; Disease Progression; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferon | 2019 |
PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression.
Topics: Acyltransferases; Fatty Liver; Hepatitis C, Chronic; Humans; Interferons; Lipase; Liver Cirrhosis; M | 2022 |
The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.
Topics: Adult; Aged; Brazil; Carrier Proteins; Fatty Liver; Female; Genetic Association Studies; Genotype; H | 2020 |
PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Follow-Up Studies; Hepatitis C, | 2020 |
PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3.
Topics: Adult; Alanine Transaminase; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; India; Interleukin | 2020 |
Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Topics: Adult; Aged; Alleles; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Female; Genetic Predispos | 2021 |
The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
Topics: Aged; Brazil; Cross-Sectional Studies; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chr | 2021 |
PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
Topics: Adult; c-Mer Tyrosine Kinase; Case-Control Studies; Female; Genetic Predisposition to Disease; Genom | 2017 |
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
Topics: Adult; Aged; Alleles; Asian People; Fatty Liver; Female; Genetic Association Studies; Genetic Predis | 2017 |
Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cross-Sectional Studies; Female; Genetic Predisposition to D | 2018 |
The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Brazil; DNA; Fatty Liver; Female; Gene Frequency; Genotype; | 2017 |
PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
Topics: Adult; Disease Progression; Disease Susceptibility; Elasticity Imaging Techniques; Female; Genetic A | 2018 |
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
Topics: Adult; Aged; Cross-Sectional Studies; Fatty Liver; Female; Genetic Predisposition to Disease; Genoty | 2018 |
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis.
Topics: Adult; Anthropometry; Biopsy; Carrier Proteins; Fatty Liver; Female; Genetic Predisposition to Disea | 2018 |
Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
Topics: Acyltransferases; Aged; Alleles; Carcinoma, Hepatocellular; Case-Control Studies; Chondroitin Sulfat | 2019 |
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Topics: Abdominal Fat; Adult; Aged; Aged, 80 and over; Apolipoprotein C-III; Fatty Liver; Female; Genotype; | 2013 |
No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Topics: Adult; Aged; Asian People; Fatty Liver; Female; Genetic Predisposition to Disease; Genotype; Hepaciv | 2013 |
PNPLA3 I148M variant as a risk factor for carotid atherosclerosis in chronic hepatitis C.
Topics: Adult; Aged; Carotid Artery Diseases; Female; Genetic Predisposition to Disease; Genetic Variation; | 2014 |
Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.
Topics: Aged; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Lipase; Logistic | 2014 |
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Topics: Adult; Coinfection; Disease Progression; Female; Genotype; Hepatitis C; Hepatitis C, Chronic; HIV; H | 2015 |
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
Topics: Adolescent; Adult; Age Factors; Aged; Disease Progression; Fatty Liver; Gene Frequency; Genetic Pred | 2014 |
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Topics: Adult; Aged; Cohort Studies; Diabetes Complications; Female; Genes, Dominant; Genes, Recessive; Gene | 2015 |
Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
Topics: Adult; Aged; Cross-Sectional Studies; Fatty Liver; Female; Genetic Predisposition to Disease; Hepati | 2015 |
TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
Topics: Adult; Analysis of Variance; Antiviral Agents; Cohort Studies; Female; Genetic Predisposition to Dis | 2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
Topics: Adult; Cohort Studies; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lip | 2015 |
PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients.
Topics: Adult; Asian People; Body Mass Index; Fatty Liver; Female; Genetic Association Studies; Genetic Pred | 2015 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
Topics: Adult; Cohort Studies; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Interferons; Interleukins; | 2016 |
A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Case-Control Studies; Female; Fibrosis; G | 2016 |
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
Topics: Aged; Antiviral Agents; Disease Progression; Fatty Liver; Female; Genome-Wide Association Study; Gen | 2015 |
Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients.
Topics: Adult; Case-Control Studies; Female; Genotyping Techniques; Hepatitis C, Chronic; Humans; Interferon | 2015 |
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Topics: Adult; Age Factors; Alleles; Biopsy; Cohort Studies; Coinfection; Cross-Sectional Studies; Disease P | 2015 |
Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.
Topics: Adult; Biopsy; Coinfection; Cross-Sectional Studies; Female; Genetic Association Studies; Genotyping | 2016 |
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
Topics: Adult; Amino Acid Substitution; Fatty Liver; Female; Genetic Predisposition to Disease; Genotype; He | 2016 |
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Topics: Adult; Allografts; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; | 2016 |
Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C.
Topics: Amylases; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interfe | 2016 |
The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Topics: Adult; Alleles; Coinfection; Cross-Sectional Studies; Disease Progression; Elasticity Imaging Techni | 2016 |
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
Topics: Adult; Carrier Proteins; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; I | 2011 |
Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C.
Topics: Alcohol Drinking; Fatty Liver; Genotype; Hepatitis C, Chronic; Humans; Lipase; Liver Cirrhosis; Memb | 2011 |
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
Topics: Adult; Alanine Transaminase; Fatty Liver; Female; gamma-Glutamyltransferase; Hepatitis C, Chronic; H | 2011 |
Focus.
Topics: Alcohol Drinking; alpha-Fetoproteins; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription F | 2011 |
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Belgium; Cross-Sectional Studies; Disease Progression; Fatty Liver; F | 2011 |
Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta-blockers.
Topics: End Stage Liver Disease; Female; Genetic Markers; Hepatitis C, Chronic; Humans; Lipase; Liver Transp | 2011 |
The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C.
Topics: Cohort Studies; Disease Progression; End Stage Liver Disease; Female; Genetic Markers; Graft Rejecti | 2011 |
Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantation.
Topics: End Stage Liver Disease; Female; Genetic Markers; Hepatitis C, Chronic; Humans; Lipase; Liver Transp | 2011 |
Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.
Topics: Fatty Liver; Hepatitis C, Chronic; Humans; Lipase; Liver Cirrhosis; Membrane Proteins | 2011 |
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Hu | 2012 |
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Topics: Adult; Aged; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Interleukins; | 2012 |
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
Topics: Adult; Alleles; Body Mass Index; Confidence Intervals; Fatty Liver; Female; Genotype; Hepatitis C, C | 2012 |
Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infection.
Topics: Fatty Liver; Hepatitis C, Chronic; Humans; Lipase; Membrane Proteins; Polymorphism, Single Nucleotid | 2012 |
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
Topics: Adult; Apoptosis; c-Mer Tyrosine Kinase; Disease Progression; Eye Proteins; Female; Genome-Wide Asso | 2012 |
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.
Topics: Asian People; Cyclooxygenase 2; Disease Progression; Female; Genetic Predisposition to Disease; Hepa | 2012 |
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Carcinoma, Hepatocellular; Female; Follow-Up Studie | 2013 |
The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
Topics: Adiponectin; Adult; Aged; Alleles; Case-Control Studies; Fatty Liver; Female; Genetic Predisposition | 2012 |
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
Topics: Carcinoma, Hepatocellular; Female; Follow-Up Studies; Genotype; Hepatitis C, Chronic; Humans; Incide | 2013 |
Hyperlipasemia associated with hepatitis C virus.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatiti | 2003 |
Pancreatic involvement in chronic viral hepatitis.
Topics: Adult; Aged; Amylases; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lipase; Male; Mid | 2005 |
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
Topics: Adult; Carbolines; Carcinoma, Hepatocellular; Diabetes Mellitus; Female; Follow-Up Studies; Hepatiti | 2008 |
Serum pancreatic enzyme concentrations in chronic viral liver diseases.
Topics: Adolescent; Adult; Aged; Amylases; Chronic Disease; Female; Hepatitis B, Chronic; Hepatitis C, Chron | 1999 |
Acute pancreatitis attributed to the use of interferon alfa-2b.
Topics: Abdominal Pain; Acute Disease; Adult; Amylases; Hepatitis C, Chronic; Humans; Injections, Subcutaneo | 2000 |